Thrombin Receptor: A Novel Target for Antiplatelet Drug Development

Author： Ray A.   Hegde L.G.   Gupta J.B.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.87, Iss.1, 1997-07, pp. : 37-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ER a Novel Estrogen Receptor Offers the Potential for New Drug Development

By Nilsson S.   Kuiper G.   Gustafsson J.-A.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 10, 1998-12 ,pp. : 387-395

Elsevier

Access to resources Recommend Favorite

12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 3, 2011-07 ,pp. : 154-164

Bentham Science Publishers

Access to resources Recommend Favorite

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 164-182

Bentham Science Publishers

Access to resources Recommend Favorite

Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite